Chronic lymphocytic leukemia(CLL).This is the most common type of leukemia in adults. Like ALL, it starts from lymphocytes in bone marrow, but it grows more slowly. Many people with CLL don't show any symptoms until years after the cancer starts. CLL mainly affects people in their 70s or...
Dr Lee categorises blood cancer into three main types:leukaemia,lymphomaandmyeloma. Each type presents unique symptoms, requiresdifferent treatment approachesand has distinct implications for patient prognosis, underscoring the need for specialised knowledge in managing these...
New Drug Shows Potential for Blood Cancer; Multiple Myeloma Patients Saw Survival Gains When Elotuzumab Was Added to TreatmentThompson, Dennis
Mount Sinai researchers have developed a new model that uses DNA and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple myeloma. They also identified potenti...
Mount Sinai researchers have developed a new model that uses DNA and RNA sequencing data from hundreds of patients to identify specific genes and genetic alterations responsible for never-before-defined subtypes of a blood cancer called multiple myeloma. They also identified potential targeted treatments...
Until recently, treatment of multiple myeloma, the second most common blood cancer, had focused on extending survival through stem cell transplants and targeted therapies. We developed a globally approved therapy that reduces the risk of disease progression and increases time in remission for patients...
Faith E. Davies, MD, has been appointed the inaugural director of Center for Blood Cancers at NYU Langone Health’s Perlmutter Cancer Center.Davies currently serves as director of the clinical myeloma program at Perlmutter Cancer Center and professo
Multiple myeloma (also known as plasma cell myeloma) is a cancer of plasma cells, specifically, the kind of white blood cell that produces antibodies to help fight infection. Based on statistics from theNational Cancer Institute, it’s currently one of the fastest growing cancer types — the ...
The US National Cancer Institute (NCI) performed the first-in-human study of a BCMA-targeting CAR-T with a murine single chain variable fragment (scFv) and a CD28 co-stimulatory domain. Twenty-four RRMM patients with a median 7.5 prior lines of therapy received lymphodepleting chemotherapy fol...
Blood Cancer Journal volume 10, Article number: 94 (2020) Cite this article 82k Accesses 139 Altmetric Metrics details Abstract The treatment of multiple myeloma (MM) continues to evolve rapidly with arrival of multiple new drugs, and emerging data from randomized trials to guide therapy. Along ...